Multifunctional Activity of a Small Tellurium Redox Immunomodulator Compound, AS101, on Dextran Sodium Sulfate-induced Murine Colitis

Macrophage biology in development, homeostasis and disease

(2013) Thomas A. Wynn et al.   NATURE

IL-17-producing γδ T cells and innate lymphoid cells

(2012) Caroline E. Sutton et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation

(2012) T Kanai et al.   Mucosal Immunology

PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice

(2011) Wei Qiu et al.   JOURNAL OF CLINICAL INVESTIGATION

Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease

(2010) H.-C. REINECKER et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Induction and Activation of Adaptive Immune Populations During Acute and Chronic Phases of a Murine Model of Experimental Colitis

(2010) Lindsay J. Hall et al.   DIGESTIVE DISEASES AND SCIENCES

The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFκB signaling pathway and nitric oxide induction in macrophages

(2010) Miri Brodsky et al.   Journal of Inflammation-London

Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis

(2010) Dei Kui Zhang et al.   JOURNAL OF PATHOLOGY

Top-down therapy for IBD: rationale and requisite evidence

(2010) Geert R. D'Haens   Nature Reviews Gastroenterology & Hepatology

Role of β7 Integrins in Intestinal Lymphocyte Homing and Retention

(2009) G. Gorfu et al.   CURRENT MOLECULAR MEDICINE

Biological Therapies for Inflammatory Bowel Diseases

(2009) Paul Rutgeerts et al.   GASTROENTEROLOGY

Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease

(2009) Nicola Eastaff-Leung et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation

(2009) Melanie A. Kleinschek et al.   JOURNAL OF EXPERIMENTAL MEDICINE

New and emerging therapies for inflammatory bowel diseases

(2009) Michael C Grimm   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injury

(2009) Miri Brodsky et al.   JOURNAL OF HEPATOLOGY

Mixed results with modulation of TH-17 cells in human autoimmune diseases

(2009) Lawrence Steinman   NATURE IMMUNOLOGY

IL-23/IL-17 immunity as a hallmark of Crohnʼs disease

(2008) Veera Hölttä et al.   INFLAMMATORY BOWEL DISEASES

Crohn's disease: beyond antagonists of tumour necrosis factor

(2008) Laurent Peyrin-Biroulet et al.   LANCET

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET

Role of cytokines in inflammatory bowel disease

(2008) Fausto Sanchez-Muñoz et al.   WORLD JOURNAL OF GASTROENTEROLOGY